Report: The third-party medical inspection industry in the Mainland will reach nearly 30 billion yuan in the next two years.

On September 5, the National Health and Family Planning Commission's Health Development Research Center released the first third-party medical laboratory effect evaluation and experience summary project report in Guangzhou on the 5th. The report shows that the third-party medical inspection industry is developing rapidly, the future. The two-year scale will grow to nearly 30 billion yuan.
Third-party medical testing industry, the main body of the carrier is a third-party medical laboratory, which is a medical institution that is licensed by the health and health administrative department and specializes in medical testing.
In mature markets such as the United States, Europe, and Japan, third-party medical laboratories are mature industries. Among them, third-party medical laboratories account for 67% of the medical test market in Japan.
The report pointed out that the third-party medical laboratory in mainland China started late, dating back to the mid-1990s. Due to market demand and technological development, a large number of hospitals have outsourced their non-inspection projects, promoting third-party medical examinations. The rapid development of the industry has increased by 40% in recent years. According to statistics, the number of independent medical laboratory and pathological diagnostics in 2017 increased to 759 and 207, an increase of 59% and 276%.
Currently, the focus is on third-party medical laboratories. enterprise Among them, Golden Mile Medicine, Dean Diagnostics, Ai Dikang ranked the top three, accounting for nearly 70% of the market share of third-party medical laboratories. Although the proportion of third-party medical testing market in the Chinese medical test market is still low, However, there is huge potential market space in the future. The market of third-party medical laboratories will maintain a growth rate of 30% to 35% from 2018 to 2020, with a scale of nearly 30 billion yuan.
In recent years, the service model of third-party medical laboratories has changed, including regional cores. hospital The regional inspection specialist medical associations established for the leading enterprises, such as the Guangzhou Conghua Maternal and Child Health Inspection Medical Association; the regional precision medical centers jointly established with the tertiary hospitals, such as the Precision Medicine Center of Qingyuan People's Hospital of Guangdong Province; Telepathology collaboration network as an example of telemedicine collaboration mode.
It is worth mentioning that under these new models, third-party medical laboratories have undertaken government public health projects, such as middle-aged and older people over 40 years old. hypertension Disease screening program, birth defects public health project services, etc., promote the service model from the point of treatment to the center health Centering for change disease The diagnosis and treatment is mainly based on prevention, and the combination of prevention and treatment.
Further analysis of the report found that under the premise of ensuring quality, third-party medical laboratories have obvious cost reduction advantages in the medical and health service system. Medical examinations are undertaken by the hospital's laboratory and pathology departments in the early stage, and the third-level hospitals can detect items usually at 300. To 500 items, there are more than a dozen primary care institutions.
For the development of the third-party medical inspection industry in the future, the report points out that the construction of third-party medical inspection institutions should be actively integrated into the classification and treatment and medical association construction, as a useful supplement to the public medical service system, improve the ability of inspection and inspection at the grassroots level, and promote the balance of medical and health resources. .
At the same time, the relevant departments can also guide third-party medical inspection institutions to provide more accurate and cost-effective precision testing, thereby reducing inspection costs, allowing chronic diseases, tumors and other diseases to be screened as early as possible, as early as possible type of symptomatic treatment.
The National Health and Family Planning Commission Health Development Research Center is affiliated to the National Health and Health Commission, a state-level research institution, and a technical advisory and think tank of the National Health and Wellness Commission.
2016 GoodChinaBrand | ICP: 12011751 | China Exports